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Abstract  27 
This study investigated metabolic, endocrine, appetite, and mood responses to a maximal eating 28 
occasion in fourteen men (mean ±SD: age 28 ±5 y, body mass 77.2 ±6.6 kg, body mass index 24.2 29 
±2.2 kg·m-2) who completed two trials in a randomised crossover design. On each occasion 30 
participants ate a homogenous mixed-macronutrient meal (pizza). On one occasion, they ate until 31 
‘comfortably full’ (ad libitum) and on the other until they ‘could not eat another bite’ (maximal). 32 
Mean [95% CI] energy intake was double in the maximal (13,024 [10964, 15084] kJ; 3113 33 
[2620,3605] kcal) compared with the ad libitum trial (6627 [5708,7547] kJ; 1584 [1364,1804] kcal). 34 
Serum insulin iAUC increased ~1.5-fold in the maximal compared with ad libitum trial (mean [95% 35 
CI] ad libitum 51.1 [33.3,69.0] nmol·L-1·4 h, maximal 78.8 [55.0,102.6] nmol·L-1·4 h, p < 0.01), but 36 
glucose iAUC did not differ between trials (ad libitum 94.3 [30.3,158.2] mmol·L-1·4 h, maximal 126.5 37 
[76.9,176.0] mmol·L-1·4 h, p = 0.19). TAG iAUC was ~1.5-fold greater in the maximal versus ad 38 
libitum trial (ad libitum 98.6 [69.9,127.2] mmol·L-1·4 h, maximal 146.4 [88.6,204.1] mmol·L-1·4 h, 39 
p < 0.01). Total GLP-1, GIP, and PYY iAUC were greater in the maximal compared with ad libitum 40 
trial (p < 0.05). Total ghrelin concentrations decreased to a similar extent, but AUC was slightly lower 41 
in the maximal versus ad libitum trial (p = 0.02). There were marked differences on appetite and 42 
mood between trials, most notably maximal eating caused a prolonged increase in lethargy. Healthy 43 
men have capacity to eat twice the calories required to achieve comfortable fullness at a single meal. 44 
Postprandial glycaemia is well-regulated following initial overeating, with elevated postprandial 45 
insulinaemia likely contributing. 46 
 47 
 48 
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 52 
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INTRODUCTION 57 
Experimental models that test the limits of human function have been instrumental in characterising 58 
the capacity and regulation of numerous physiological systems, including the capacity for maximal 59 
oxygen uptake(1), time spent without energy intake(2), and most recently maximal levels of sustained 60 
energy expenditure(3). This approach advances our fundamental understanding of human physiology 61 
and provides important insights into susceptibility towards pathophysiology. For over 100 years, 62 
however, our knowledge about metabolic health and disease has been derived almost entirely from 63 
experiments that investigate an appropriate quantity of food, either according to prescribed 64 
requirements or perceived hunger. A major rationale for such studies is to address the negative health 65 
outcomes associated with obesity, which is caused by an inappropriate quantity of food being 66 
consumed – with nutrient consumption exceeding energy requirements.  67 
 68 
It is remarkable that, to our knowledge, no study has ever examined the metabolic response to eating 69 
beyond feeling comfortably full in a single eating occasion. Indeed, even more general data on the 70 
physiological limits of human eating are scarce. Some data from the Masa tribe of Cameroon suggest 71 
humans can sustain intake of ~8700 kilocalories per day for 2 months, and gain ~11 kg of adipose 72 
tissue as a result, but no metabolic outcomes were measured(4). Metabolic effects of prescribed 73 
overfeeding are better understood, revealing disruption of glycaemic control after just 24 hours when 74 
a 78% energy surplus is prescribed(5). Similar detriments to glycaemic control have been well-75 
characterised following 7 days energy surplus of ~50%(6,7,8). This disruption of glycaemia results in 76 
marked increases in triglyceride (TAG) and very-low-density lipoprotein-TAG (VLDL-TAG) 77 
concentrations, and reduced VLDL-TAG clearance, after 4 days in healthy men(9). Nonetheless, these 78 
studies did not test the capacity, or the metabolic consequences, of a maximal effort to overeat.  79 
 80 
Data on the metabolic consequences of eating to the limits of human physiology will provide novel 81 
insights regarding the physiological responses to common overeating that drives our ongoing obesity 82 
epidemic and the extreme overeating that occurs on certain occasions. Moreover, investigating 83 
extremes is an effective method to fully understand how systems are regulated more generally – so 84 
this approach may advance future understanding of the mechanisms associated with human obesity 85 
and metabolism, thus identifying potential targets for body weight management and metabolic health. 86 
In the present study, we established the metabolic, endocrine, appetite, and mood responses to both 87 
eating until comfortably full and eating beyond comfortably full to the perceived point of maximal 88 
eating.  89 
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EXPERIMENTAL METHODS 90 
Study design 91 
Fourteen men (mean±SD: age 28±5 y, body mass 77.2±6.6 kg, height 1.79±0.05 m, body mass index 92 
24.2±2.2 kg∙m-2) completed a randomised crossover study with two trials. On one occasion 93 
participants ate a homogenous mixed-macronutrient meal (Margherita cheese and tomato pizza) until 94 
they were comfortably full, and on the other occasion they were asked to eat the same food but until 95 
they could not eat another bite. Metabolic, endocrine, appetite, and mood responses to the test meals 96 
were measured for 4 h following ingestion of the first bite. This study was approved by the Research 97 
Ethics Committee for Health (REACH; reference number EP 17/18 168) at the University of Bath. 98 
Inclusion criteria were a body mass index (BMI) between 18.5-29.9 kg∙m-2, age between 18-65 years, 99 
able and willing to consent to the study procedures, and no anticipated change in lifestyle between 100 
trial dates. Exclusion criteria were any reported condition or behaviour/any reported use of substances 101 
which may pose undue personal risk to the participant or introduce bias to the experiment, or any 102 
diagnosed metabolic disease. Trials were separated by a mean±SD (range) of 33±20 (14 – 76) days.  103 
Randomisation was completed by AH using www.randomizer.org. Water intake was permitted ad 104 
libitum throughout each trial. 105 
 106 
Preliminary measures  107 
Participants were asked to adhere to their habitual diet and physical activity for the 48 hours preceding 108 
trial days. They recorded what they ate for dinner the evening before their trial day and replicated this 109 
before their second trial day. Participants were asked to record how they commuted to the laboratory 110 
on the morning of the trial day and replicate this for the second trial day. Participants were asked to 111 
consume a pint of water between waking and travelling to the laboratory. 112 
 113 
Anthropometric measures 114 
Participants arrived in the laboratory at ~10:00 h having fasted for >10 hours. Height was measured 115 
using a stadiometer in the Frankfurt plane (Harpenden, Holtain Ltd., UK). Body mass was measured 116 
using a balance scale (Weylux 424, H. Fereday & Sons Ltd., UK) with participants wearing light 117 
clothing. Waist and hip circumference were measured using a handheld tape measure (Seca Ltd., 118 
Birmingham, UK). Sagittal abdominal diameter was measured at end tidal volume with participants 119 
laying supine with their legs bent at 45o using an abdominal caliper (Holtain Ltd., UK).  120 
 121 
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Whole-body physiological measures 122 
Participants were asked to sit, and tympanic temperature was measured using a handheld thermometer 123 
(Braun Thermoscan, Frankfurt, Germany). Blood pressure and heart rate were measured using an 124 
automated sphygmomanometer (Diagnostec EW3106, Panasonic, Japan). Hand grip strength was 125 
measured using a handheld dynamometer (T.K.K.5001 GRIP A, Takei Scientific Instruments Co. 126 
Ltd., Japan). Participants remained seated with the arm straightened proximal to the body and the 127 
highest of 3 attempts was recorded.  128 
 129 
Blood sampling and analysis 130 
A cannula (BD VenflonTM Pro, Becton Dickenson & Co., Sweden) was inserted antegrade into an 131 
antecubital forearm vein ~15-45 minutes prior to ingestion of the meal. A 5 mL of blood was drawn 132 
at each sample. The cannula was flushed with sterile NaCl 0.9% (B. Braun, Pennsylvania, USA) to 133 
maintain patency throughout the trial (repeated at each blood sample; 0, 30, 60, 90, 120, 240 minutes). 134 
Blood samples were aliquoted into sterile collection tubes (Sarstedt, Nümbrecht, Germany). Samples 135 
were left to clot at room temperature for 15 minutes before being centrifuged at 4000 x g for 10 136 
minutes at 4oC. Serum was placed on dry ice then stored at -80oC awaiting analyses. Serum glucose, 137 
triacylglycerol (TAG), non-esterified fatty acids (NEFA), and lactate were measured using 138 
commercially available assay kits on an automated analyser (RX Daytona, Randox Laboratories Ltd., 139 
UK). Inter-assay CV was < 3% for glucose, < 2% for TAG, < 7% for NEFA, and < 3% for lactate. 140 
Intra-assay CV was < 2% for glucose, < 2% for TAG, < 5% for NEFA, and < 3% for lactate. Serum 141 
insulin was measured using a commercially available enzyme-linked immunosorbent assay (ELISA) 142 
kit (Mercodia AB, Uppsala, Sweden), with an intra-assay CV of < 5%. Serum total ghrelin, total 143 
glucose-dependent insulinotropic peptide (GIP), total glucagon-like peptide-1 (GLP-1), and total 144 
peptide tyrosine-tyrosine (PYY) were measured using commercially available ELISA kits 145 
(MilliporeSigma, Massachusetts, USA). Intra- and inter-assay CV was < 4% and < 7% for ghrelin, < 146 
5% and < 7% for GIP, < 8% and < 15% for GLP-1, and < 8% and < 12% for PYY.  147 
 148 
Appetite and mood ratings 149 
Participants completed a series of 0-100 mm appetite and mood scales, with each scale ranging from 150 
‘Not at all’ (0) to ‘Extremely’ (100). They were instructed to draw a straight vertical line on the scale 151 
relating to how they felt in relation to a number of statements at the time of measurement. Statements 152 
asked included: ‘I feel hungry’, ‘my stomach feels full’, ‘I have desire to eat something savoury’, ‘I 153 
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have desire to eat something sweet’, ‘I feel physically tired’, ‘I feel sleepy/drowsy/half awake’, ‘I 154 
feel energetic/active/lively’, and ‘I feel lethargic/sluggish’. The scales were completed at baseline, 155 
immediately following cessation of the meal, and at 4-hours following ingestion of the first bite. 156 
Appetite and mood ratings have previously been validated for use in nutrition research(10,11).  157 
 158 
Test meal 159 
The test meals were delivered to the laboratory at 11:00 h and were sliced by the research team into 160 
small, consistently portioned, slices to serve to the participants (mean ±SD slice weight 77.5±18.5 g, 161 
range 40.3-145.4 g, n = 305). The test meal was Domino’s® Original Cheese & Tomato Classic Crust 162 
pizza. Nutrition information per 100 g: energy 284 kcal, fat 10.3 g, of which saturates 5.5 g, 163 
carbohydrate 33.5 g, of which sugars 6.7 g, fibre 2.0 g, protein 13.4 g, salt 1.31 g (obtained online 164 
21/06/18). In the ad libitum trial participants were instructed to ‘eat until you are comfortably full’, 165 
‘eat all you would like to eat’, and ‘until you have satiated your hunger’. In the maximal trial they 166 
were instructed ‘this is maximal eating’, ‘eat all you can eat’, and ‘until you cannot physically eat 167 
another bite’. Up to four participants completed their trial at the same time with tables facing the 168 
corner of the room. During the test meal, participants were asked not to communicate with each other. 169 
Participants were instructed to place their hand in the air when they had finished a pizza slice and 170 
wanted another. Participants weighed the slice when they received it using portable weighing scales 171 
(Smart Weigh, China) and recorded the time on their stopwatch each time they finished a slice. If a 172 
slice could not be finished the leftovers were weighed. Energy and nutrient intakes were determined 173 
by multiplying the energy density of the food by the mass of food consumed.  174 
 175 
When participants finished ingesting the pizza, measures of waist and hip circumference, sagittal 176 
abdominal diameter, tympanic temperature, blood pressure, heart rate, hand grip strength, and 177 
appetite/mood ratings were obtained. These measures were repeated a final time at 240 minutes 178 
following ingestion of the first bite. Blood samples were obtained at 30, 60, 90, 120, 180, and 240 179 
minutes following ingestion of the first bite of pizza. Blood pressure was measured at 60, 120, 180, 180 
and 240 minutes following ingestion of the first bite of pizza. Participants sat upright on chairs for 181 
the duration of each trial. Participants were not permitted to perform any activities other than eating 182 
during the feeding period. Once they had indicated they no longer wished to eat they could engage in 183 
sedentary activities like reading, using a smartphone, or using a laptop.  184 
 185 
 186 
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Statistical analyses 187 
Descriptive statistics were calculated using Microsoft Excel (Microsoft, Washington, USA). Energy 188 
intake, area under the curve (AUC), and incremental area under the curve (iAUC) were compared 189 
using a paired t-test. Paired data were first assessed for a normal distribution using a Shapiro-Wilk 190 
test, along with visual inspection of frequency distributions (Wilcoxon tests applied wherever paired 191 
differences deviated significantly from a normal distribution). Similarly, the possibility of order 192 
effects between treatments for the above parameters was explored using a 2-way ANOVA with 193 
Condition, Order and Condition-by-Order terms included in the model, along with visual inspection 194 
of individual responses under each sequence (there were no significant main effects of trial order for 195 
any variable and reported effects of condition were evident irrespective of the order in which 196 
conditions were applied). Baseline data were also subjected to this same analysis for trial order 197 
effects, which revealed no differences between the first and second trial for any outcome. For all other 198 
outcomes that involved time-series measurements within trials, two-way repeated measures ANOVA 199 
was used to detect significant time, trial, or time x trial interactions, with post-hoc Šidák corrections 200 
applied using GraphPad Prism (GraphPad Software Inc., California, USA). Significance was 201 
accepted as p ≤ 0.05. Data are presented as mean [lower 95% confidence interval (CI), upper 95% 202 
CI] unless otherwise stated.  203 
 204 
RESULTS 205 
Energy intake and eating rate 206 
Energy intake was 6397 [4481, 8313] kJ (mean [95% CI]; 1529 [1071, 1987] kcal) greater in the 207 
maximal trial compared with the ad libitum trial (Figure 1A). Eating rate appeared to be similar 208 
between trials (Figure 1B). Mean ±SD eating time was 16 ±5 minutes for the ad libitum trial and 53 209 
±13 minutes for the maximal trial (p < 0.01). Mean nutrient intakes from each trial and reference 210 
nutrient intakes for UK adults are displayed in Table 1. Mean ±SD pizza slices were 76 ±20 g, there 211 
were no differences in pizza slices between trials (ad libitum 75 ±21 g, maximal 76 ±20 g, p = 0.60).  212 
[Insert Figure 1 around here] 213 
[Insert Table 1 around here] 214 
 215 
 216 
 217 
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Metabolic responses 218 
Serum insulin concentrations increased more in the maximal trial versus ad libitum (Figure 2A).  219 
Serum insulin iAUC was 55% greater in the maximal (67.7 [47.0, 88.5] nmol∙L-1∙4h) versus ad libitum 220 
trial (43.8 [28.3, 59.3] nmol∙L-1∙240 min, p < 0.01; Figure 2B). Serum glucose concentrations were 221 
not significantly different between trials (Figure 2C). Serum glucose iAUC did not differ between 222 
trials (p = 0.19; Figure 2D).  223 
 224 
Serum TAG concentrations remaining significantly elevated in the maximal versus ad libitum trial 225 
(Figure 2E). Serum TAG iAUC was greater in the maximal trial versus ad libitum (p < 0.01; Figure 226 
2F). Serum NEFA concentrations were not statistically different between trials (Figure 2G). Serum 227 
NEFA AUC tended to be greater in maximal trial versus ad libitum (p = 0.06; Figure 2H). There was 228 
a condition-by-order interaction effect (p = 0.01) for serum NEFA AUC but no order effect per se (p 229 
= 0.41). Serum lactate concentrations were similar between trials, but decreased in both trials at 30 230 
minutes compared to baseline (Figure 2I). Serum lactate AUC was similar between the trials (p = 231 
0.14; Figure 2J).  232 
[Insert Figure 2 around here] 233 
 234 
Gut hormones 235 
Serum total ghrelin concentrations decreased in both trials without differences between trials (Figure 236 
3A). Serum total ghrelin AUC was lower in the maximal trial than ad libitum (p = 0.02; Figure 3B). 237 
There was a condition-by-order interaction effect for serum ghrelin AUC (p = 0.04) but no effect of 238 
order per se (p = 0.08). Serum total GIP concentrations increased more in the maximal trial compared 239 
with ad libitum at 240-minutes postprandial (Figure 3C). Serum total GIP iAUC was greater in the 240 
maximal trial compared with ad libitum (p < 0.01; Figure 3D). Serum total GLP-1 concentrations 241 
increased more in the maximal trial than ad libitum (Figure 3E). Serum total GLP-1 iAUC was 242 
greater in the maximal trial than the ad libitum trial (p < 0.01; Figure 3F). Serum total PYY 243 
concentrations increased more in the maximal trial than ad libitum by 240-minutes postprandial 244 
(Figure 3G). Serum total PYY iAUC was greater in the maximal trial than ad libitum (p = 0.03; 245 
Figure 3H).  246 
[Insert Figure 3 around here] 247 
 248 
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Anthropometry and whole-body responses 249 
Systolic blood pressure increased in the postprandial period in both trials (time effect: p < 0.01; 250 
condition effect: p = 0.03; time x condition interaction effect: p = 0.31; Table 2). Diastolic blood 251 
pressure did not differ at baseline or across the postprandial period between trials, (time effect: p = 252 
0.33; condition effect: p = 0.64; time x condition interaction effect: p = 0.24; Table 2). Heart rate 253 
increased from baseline in both trials (time effect: p < 0.01) but increased more in the maximal trial 254 
compared with ad libitum (condition effect: p = 0.02; time x condition interaction effect: p = 0.02; 255 
Table 2).  256 
[Insert Table 2 around here] 257 
 258 
Waist circumference increased in the both trials following ingestion of the meal (time effect: p < 0.01; 259 
condition effect: p = 0.01; time x condition interaction effect: p = 0.22) (Table 3). Hip circumference 260 
demonstrated a trivial increase in both trials (time effect: p < 0.01), with no differences detected 261 
between trials (condition effect: p = 0.48; time x condition interaction: p = 0.64; Table 3). Sagittal 262 
abdominal diameter increased more in the maximal trial immediately post-eating and 240-minutes 263 
following ingestion of the test meal (time effect: p < 0.01; condition effect: p < 0.01; time x condition 264 
interaction effect: p < 0.01; Table 3). Tympanic temperature increased marginally during the 265 
postprandial period in both trials (time effect: p < 0.01; condition effect: p = 0.46; time x condition 266 
interaction effect: p = 0.14; Table 3). Hand grip strength decreased marginally in both trials (time 267 
effect: p < 0.01; condition effect: p = 0.25; time x condition interaction effect: p = 0.74; Table 3).  268 
[Insert Table 3 around here] 269 
 270 
Appetite and mood ratings 271 
Hunger decreased in both trials and remained significantly lower by 240-minutes postprandial in the 272 
maximal trial versus ad libitum (Figure 4A). Fullness increased to a greater extent in the maximal 273 
trial versus ad libitum and subsequently declined at the same rate to 240 minutes (Figure 4B). Desire 274 
for savoury food decreased to very low levels in both trials, but was significantly lower at 240 minutes 275 
in the maximal trial versus ad libitum (Figure 4C). Desire for sweet food decreased only for the 276 
maximal trial, remaining significantly lower than for the ad libitum trail at 240 minutes (Figure 4D). 277 
 278 
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Physical tiredness increased and was higher throughout the maximal trial versus ad libitum (Figure 279 
4E). Sleepiness did not change in the ad libitum trial, however remained elevated throughout the 280 
postprandial period in the maximal trial (Figure 4F). Energetic feelings decreased markedly 281 
throughout the postprandial period in the maximal trial (Figure 4G). Ratings of lethargy increased 282 
significantly and substantially in the maximal trial (versus ad libitum) and remained elevated (Figure 283 
4H). 284 
[Insert Figure 4 around here] 285 
 286 
 287 
Relative changes 288 
The relative (percentage) changes between the maximal trial and the ad libitum trial are presented in 289 
Figure 5. Whilst energy intake was 102±57% (mean±SD) greater in the maximal trial, most other 290 
outcomes remained similar between trials. GLP-1 iAUC (97±79%; mean±SD) and insulin iAUC 291 
(57±53%) displayed the most variability of other outcomes between trials.  292 
[Insert Figure 5 around here] 293 
 294 
DISCUSSION 295 
The present study is the first to assess the metabolic and appetite responses to maximal eating. Mean 296 
energy intake doubled when participants were asked to eat a maximal amount compared with ad 297 
libitum eating, and all participants consumed more energy (between 29% and 227% more calories) 298 
in the maximal trial compared to ad libitum. Notwithstanding this doubling of energy intake, many 299 
of the physiological responses remained well-controlled within the postprandial period. 300 
 301 
We observed that glycaemic control is well-maintained following an initial overeating occasion. In 302 
the present study, serum glucose concentrations were tightly regulated in both trials, such that eating 303 
twice as much energy, and ~180 g more carbohydrate, did not alter the 4 h postprandial glucose 304 
response in proportion to the increased carbohydrate load. These responses do not suggest the 305 
maximal feeding impaired glycaemic control. These responses may be due to greater rates of insulin-306 
stimulated glucose uptake into peripheral tissues including skeletal muscle(12) and adipose tissue(13) 307 
in the maximal trial versus ad libitum. This potential mechanism is consistent with the elevated 308 
postprandial insulin concentrations measured throughout the maximal trial versus ad libitum. 309 
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Increasing insulinaemia across the ranges observed in the present study dose-dependently increases 310 
peripheral glucose disposal rates(14). It is therefore likely that glucose clearance rates were increased 311 
to maintain similar circulating concentrations between trials. This is consistent with other work using 312 
stable isotope tracers following 5 days of habitual macronutrient overfeeding in healthy men(15). It is 313 
also important to consider the role of gastric emptying, which is delayed by increasing the energy 314 
content of a meal per se(16), whereas (over)consumption of specific macronutrients within a meal 315 
alters gastric emptying rates compared to consuming carbohydrates alone. Ingestion of 25 g, 50 g, 75 316 
g, and 100 g of carbohydrate from bread results in an proportional increase in postprandial 317 
glycaemia(17), however, when fat is added to a carbohydrate-rich meal, gastric emptying can be 318 
delayed and postprandial glycaemia can be attenuated(18). Furthermore, gut hormones (GLP-1, 319 
ghrelin, and PYY) may have played an important role in the postulated delay of gastric emptying 320 
with maximal eating(19,20,21). We cannot dismiss the possibility of a type 2 error whereby we were 321 
underpowered to detect a change in glucose response to maximal eating, however based on our results 322 
any effect is likely to be small. Postprandial glycaemia is well-maintained following an initial 323 
overeating occasion, with elevated insulinaemia and delayed gastric emptying likely contributing to 324 
this control.  325 
 326 
Postprandial lipaemic responses were increased following a maximal eating occasion. Ingestion of 327 
excessive energy in the maximal trial led to an increased postprandial triglyceridaemia and a tendency 328 
for elevated NEFA concentrations. A trend towards higher NEFA concentrations following maximal 329 
eating in the present study may indicate spillover of dietary fatty acids into the circulating NEFA 330 
pool(22). When fat is ingested alone, postprandial TAG responses across a 4 h period increase in direct 331 
proportion to the increase in fat ingested(23), but when carbohydrate(24,25) or protein(26) are added to 332 
oral fat ingestion, postprandial triglyceridaemia is attenuated. This potentially explains the relatively 333 
modest increase in postprandial TAG in the present study, which was ~1.5-fold, despite a 2-fold 334 
increase in fat intake. However, it should be acknowledged that we observed a relatively short 335 
postprandial period for investigating TAG responses; significant trial differences were only observed 336 
between 2 and 4 hours postprandial. A duration of 6-8 hours may have been more appropriate for 337 
assessment of postprandial lipid metabolism(27). However, the duration we measured was the same as 338 
previous data showing a doubling of lipaemia with fat ingestion alone(23), so it is unlikely there would 339 
be a doubling of lipaemia from the present study meal if we had measured for 8 hours. Elevated 340 
postprandial insulinaemia likely contributes to regulating postprandial TAG concentrations by 341 
suppressing hepatic very-low density lipoprotein secretion and reducing availability of NEFA to the 342 
liver(28). Insulin also stimulates adipose tissue lipoprotein lipase activity and therefore increases 343 
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uptake of fatty acids into adipose tissue(29). Consumption of a maximal amount of food increases 344 
postprandial lipaemia in the initial 4-hour postprandial period, but to a lesser extent than expected 345 
based on the fat content of the meal alone.  346 
 347 
A maximal eating occasion produced variable gut hormone responses in the present study. Both GIP 348 
and GLP-1 potentiate glucose-stimulated insulin secretion(30,31), which may have contributed to the 349 
elevated postprandial insulinaemia we observed in the maximal trial. Ghrelin and GIP are primarily 350 
secreted proximally along the gastrointestinal tract in the stomach and duodenum(32,33), whereas GLP-351 
1 and PYY are secreted more distally along the gastrointestinal tract towards the ileum and colon(33,34).  352 
Ghrelin and GIP were less impacted by eating beyond comfortable fullness in the maximal trial, 353 
compared with the larger increases observed in GLP-1 and PYY between the trials. This suggests that 354 
the more proximally secreted gut hormones may be saturated when consuming food until comfortable 355 
fullness, whereas the physiological limit of GLP-1 and PYY secretion are not reached until eating 356 
beyond comfortable fullness. The greater suppression of postprandial ghrelin in response to maximal 357 
eating observed in the present study is consistent with previous research showing that postprandial 358 
ghrelin AUC decreases with an increase in energy content of the meal, but with no differences 359 
between 2000 and 3000 kilocalorie meals(35), which suggests ghrelin was suppressed to near maximal 360 
from ad libitum eating of a mixed-macronutrient meal. It should be noted that we measured total 361 
concentrations of each gut hormone. Measuring all isoforms of each gut hormone would provide 362 
greater understanding of responses to a maximal feeding stimulus. 363 
 364 
The cessation of eating in the present study could have been due to energy sensing and/or gastric 365 
distension. Waist circumference and sagittal abdominal diameter increased to a greater extent in the 366 
maximal trial versus ad libitum. Food volume, energy density, and macronutrient composition all 367 
influence postprandial fullness(36,37), so in the present study we can only infer that individuals reached 368 
the maximal energy intake they could achieve from food with an energy density of 2.84 kilocalories 369 
per gram. We purposely chose a palatable and energy dense food for the present study, exploring 370 
maximal capacity to feed with foods of different energy densities could be worthwhile for 371 
investigating the contribution of both volume and energy sensing to feelings of fullness. Furthermore, 372 
measuring the habitual energy density of the diet for participants could be important – for example, 373 
individuals with a more energy sparse diet may achieve a higher volume of food intake on a regular 374 
basis to achieve energy balance, whereas energy dense diets require a lower volume of food for a 375 
similar nutrient intake. This may result in an adaptive response that dictates the capacity to overeat 376 
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in response to a test meal with a fixed energy density. It is also noteworthy that the postprandial 377 
period from cessation of the test meal was different between trials, and this may have influenced the 378 
magnitude of the differences we observed in response to the magnitude of difference in energy intake. 379 
The duration of the postprandial period could be matched in future studies with timers started at the 380 
onset and cessation of food intake.  381 
 382 
More generally, the present results demonstrate that values typical for daily metabolic requirements 383 
can be met in a single meal of moderately energy dense food. This relates to the capacity of healthy 384 
humans to eat in substantial excess of energy needs, with conscious restraint and/or other strategies 385 
being required to avoid this occurring regularly(38,39). There is an acute cost of overeating, including, 386 
as demonstrated in this study, increased feelings of sleepiness, lethargy and physical tiredness, and 387 
reduced feelings of energy. The notion of postprandial somnolence is well-established, although the 388 
mechanisms are not well-understood. Cerebral blood flow does not decrease following ad libitum 389 
(≥1200 kcal) ingestion of  pizza(40), which refutes the theory that postprandial blood flow is 390 
redistributed away from the brain and toward the mesentery following normal feeding occasions – 391 
although it is possible that the volume ingested in the maximal trial in the present study could have 392 
influenced cerebral blood flow, which would require assessment in future work. Consistent with a 393 
challenge to haemodynamic control, we observed a greater heart rate response to maximal versus ad 394 
libitum eating. A vast array of peptides are secreted by the gastrointestinal tract in response to 395 
feeding(41) and many of these are known to act as neuropeptides to influence appetite control(42). It 396 
has also been hypothesised that postprandial release of gastrointestinal hormones and their action on 397 
the hypothalamus may characterise a controlled process of postprandial somnolence(43), perhaps with 398 
the function encouraging the diner to rest, and thereby keep safe, while they digest. Our present data, 399 
however, do not show any correlations between the change in gut hormone concentrations and 400 
increased sleepiness (not displayed). Nonetheless, irrespective of mechanisms, it seems likely that 401 
postprandial somnolence, and its avoidance, plays a significant role in shaping meal patterns. Most 402 
obviously, for example, motivation to work and work efficiency will be higher if the meal just eaten, 403 
be it breakfast or lunch, is modest size rather than the maximum or near maximum than can be 404 
eaten(39,44,45). It is notable, therefore, that the amount that participants chose to eat in the ad libitum 405 
meal, to be ‘comfortably full’, had rather little impact on mood, including causing no increase in 406 
postprandial lethargy and sleepiness. To our knowledge, it is not known whether feelings of tiredness 407 
translate to reduced postprandial physical activity energy expenditure (PAEE). If this were to be the 408 
case, individuals who overeat frequently could be caught in an undesirable cycle of increased energy 409 
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intake and reduced PAEE, making it more difficult to achieve a negative energy balance and 410 
increasing the risk of developing obesity. This is an important avenue for future research.  411 
 412 
Consistent with the phenomenon of sensory-specific satiety(39,46), desire for savoury foods was 413 
satiated in both trials immediately following ingestion of the (savoury) test meal, but only recovered 414 
substantially by the end of the postprandial period in the ad libitum trial – by which time the next 415 
usual eating occasion may often occur based on a pattern of three main meals and snacks across the 416 
day(47). Desire for sweet foods was not satiated at all in the ad libitum trial, confirming that the decline 417 
in the reward value was specific to savoury food and supporting the theory that, even in the immediate 418 
postprandial period, humans are almost always ready to eat, even when apparently satiated(38,39). 419 
However, following eating in the maximal trial, the desire for sweet food was satiated despite the 420 
meal consumed being primarily savoury, demonstrating, as might be expected(48), the complete 421 
inhibition of desire to eat by extreme fullness. 422 
 423 
The present study intended to recruit both males and females. Unfortunately, no females enrolled on 424 
the present study, but future research should aim to repeat the study in females to identify any 425 
potential sex-differences that may occur or provide a more complete evidence base regarding these 426 
findings. Furthermore, we obtained venous samples. Whilst the use of venous blood is appropriate in 427 
a crossover design as any differences are within-subject, our research has previously shown that 428 
arterialising venous samples by heating a dorsal hand vein can influence the measurement of 429 
postprandial glucose and GLP-1 concentrations(49,50). Future studies should characterise the 430 
postprandial responses to nutrients using arterialised blood. The differences we observed between 431 
conditions for blood measures may be dependent on the length of the postprandial period – a longer 432 
postprandial period where concentrations of various outcomes return to baseline would provide more 433 
information about the differences between conditions.  In the present study, meals were ordered from 434 
a fast food restaurant; therefore, we cannot guarantee the macronutrient composition was identical 435 
across trials. We studied a cohort of men of a healthy weight; in future, it would be interesting to 436 
characterise the capacity to overeat in people with obesity and the subsequent metabolic effects to an 437 
initial overeating occasion in this population. Furthermore, it would be fascinating to measure the 438 
capacity and metabolic effects of individuals who are able to achieve extreme energy intakes in one 439 
sitting.  440 
 441 
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In summary, our study shows that healthy men have the capacity to eat twice as much energy as 442 
required to achieve comfortable fullness at a single meal. Postprandial glycaemia is well-regulated in 443 
response to this initial overeating occasion, with elevated postprandial insulinaemia likely 444 
contributing to the maintenance of glucose control. Postprandial serum triglyceride concentrations 445 
are elevated following an initial overfeed, but not in direct proportion to the fat content of the meal. 446 
Gut hormones continue to be secreted/suppressed when individuals eat beyond comfortably full, but 447 
the magnitude of the change is not consistent between hormones and this may be dictated by their 448 
site of secretion along the gastrointestinal tract. Following an initial maximal feed, participants 449 
reported no desire for sweet foods despite not eating any sweet foods. Feelings of lethargy and 450 
sleepiness are elevated following maximal eating in healthy men. These results demonstrate the 451 
physiological capacity of healthy humans to deal with a considerable energy surplus in the form of a 452 
maximal eating occasion. 453 
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TABLES 501 
Table 1. Mean ± SD nutrient intakes following ad libitum and maximal eating. Daily reference 502 
nutrient intakes (RNI) for UK adults are displayed for comparison 5.  503 
 ad libitum maximal RNI for one day 
Fat (g) 57.4 ± 13.8 112.9 ± 30.9 70.0 
of which saturates (g) 30.7 ± 7.4 60.3 ± 16.5 20.0 
Carbohydrate (g) 186.8 ± 44.9 367.2 ± 100.6 260.0 
of which sugars (g) 37.4 ± 9.0 73.4 ± 20.1 90.0 
Fibre (g) 3.7 ± 0.9 7.3 ± 2.0 30.0 
Protein (g) 74.7 ± 18.0 146.9 ± 40.2 50.0 
Salt (g) 7.3 ± 1.8 14.4 ± 3.9 6.0 
 504 
 505 
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 507 
 508 
 509 
 510 
 511 
 512 
 513 
 514 
 515 
 516 
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Table 2. Blood pressure and heart rate responses to ad libitum or maximal eating. Data 517 
presented are mean ± SD.  518 
Time (min)  0 60 120 180 240 
Systolic 
pressure 
(mmHg) 
ad libitum 121 ± 9 126 ± 10 124 ± 11 125 ± 14 123 ± 11 
maximal 122 ± 10 134 ± 16 129 ± 11 130 ± 11 127 ± 11 
Diastolic 
pressure 
(mmHg) 
ad libitum 68 ± 6 63 ± 7 63 ± 8 64 ± 10 65 ± 8 
maximal 65 ± 8 65 ± 8 67 ± 8 66 ± 6 64 ± 8 
Heart rate 
(beats per 
minute) 
ad libitum 58 ± 9 65 ± 8 64 ± 7 60 ± 7 58 ± 8 
maximal 58 ± 9 72 ± 7* 69 ± 6* 66 ± 5* 65 ± 6* 
*p < 0.05 vs same time point in ad libitum  519 
 520 
 521 
 522 
 523 
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 525 
 526 
 527 
 528 
 529 
 530 
 531 
 532 
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Table 3. Anthropometric and whole-body responses to the test meals following ad libitum and 534 
maximal eating. Data presented are mean ± SD.  535 
Time (min)  0 30 240 
Waist circumference (cm) 
ad libitum 81.6 ± 5.1 83.4 ± 5.0  83.2 ± 4.9  
maximal 82.3 ± 5.3  84.9 ± 4.3 84.9 ± 5.5 
Hip circumference (cm) 
ad libitum 100.7 ± 3.8 101.4 ± 3.2 101.7 ± 3.5 
maximal 100.5 ± 3.2 100.7 ± 3.2 101.5 ± 3.6 
Sagittal abdominal diameter (cm) 
ad libitum 18.6 ± 1.2 19.3 ± 1.3 19.2 ± 1.6 
maximal 18.6 ± 1.4 20.4 ± 1.2* 19.9 ± 1.4* 
Tympanic temperature (oC) 
ad libitum 36.5 ± 0.3 36.7 ± 0.2 36.6 ± 0.3 
maximal 36.4 ± 0.3 36.6 ± 0.4 36.7 ± 0.3 
Hand grip strength (kg) 
ad libitum 55.7 ± 8.2 53.6 ± 7.6 53.4 ± 7.9 
maximal 54.8 ± 8.2 52.1 ± 6.3 52.8 ± 7.6 
*p < 0.05 vs same time point in ad libitum  536 
 537 
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FIGURE LEGENDS 683 
Figure 1. A) Mean, 95% confidence interval, and individual energy intake achieved during an 684 
ad libitum and maximal eating occasion (condition effect p < 0.01). Macronutrient contribution 685 
to energy intake is displayed. CHO = carbohydrate, PRO = protein. B) Individual eating rate 686 
towards cessation of eating during an ad libitum and maximal eating occasion.  687 
 688 
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Figure 2. Mean (±95 CI) serum concentrations of 689 
insulin (A, condition effect: p = 0.03, time x 690 
condition interaction effect: p = 0.13), glucose (C, 691 
trial effect: p = 0.09, time x condition interaction 692 
effect: p = 0.28), TAG (E, condition effect: p = 693 
0.10; time x condition interaction effect: p < 0.01), 694 
NEFA (G, condition effect: p = 0.15; time x trial 695 
interaction effect: p = 0.24), and lactate (I, time 696 
effect: p < 0.01; condition effect: p = 0.16; time x 697 
condition interaction effect: p = 0.84) in the 4-hour 698 
postprandial period following an ad libitum and 699 
maximal eating occasion. Mean (±95 CI) and 700 
individual incremental area under the curve for 701 
serum insulin (B), glucose (D), TAG (F) and total 702 
area under the curve for serum NEFA (H) and 703 
lactate (J) across the 4-hour postprandial period 704 
following an ad libitum and maximal eating 705 
occasion. iAUC = incremental area under the 706 
curve, AUC = area under the curve, TAG = 707 
triacylglycerol, NEFA = non-esterified fatty acids. 708 
#Wilcoxon test used as data non-normally 709 
distributed.  *p < 0.05. 710 
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Figure 3. Mean (±95 CI) serum 720 
concentrations of total ghrelin (A, 721 
condition effect: p = 0.23; time x condition 722 
interaction effect: p = 0.15), total GIP (C, 723 
condition effect: p = 0.02; time x condition 724 
interaction effect: p = 0.12), total GLP-1 725 
(E, condition effect: p < 0.01; time x 726 
condition interaction effect: p < 0.01), and 727 
total PYY (G, condition effect: p = 0.07; 728 
time x condition interaction effect: p < 729 
0.01) in the 4-hour postprandial period 730 
following an ad libitum and maximal eating 731 
occasion. Mean (±95 CI) and individual 732 
area under the curve for serum total 733 
ghrelin (B) and incremental area under the 734 
curve for total GIP (D), total GLP-1 (F), 735 
and total PYY (H) across the 4-hour 736 
postprandial period following an ad libitum 737 
and maximal eating occasion. iAUC = 738 
incremental area under the curve, AUC = 739 
area under the curve, GIP = glucose-740 
dependent insulinotropic peptide, GLP-1 = 741 
glucagon-like peptide-1, PYY = peptide 742 
tyrosine-tyrosine. *p < 0.05. 743 
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Figure 4. Mean (±95 CI) scores for 750 
ratings of hunger (A, condition effect: 751 
p < 0.01; time x condition interaction 752 
effect: p < 0.01), fullness (B, time 753 
effect: p < 0.01; condition effect: p < 754 
0.01; time x condition interaction 755 
effect: p = 0.02), desire for savoury 756 
food (C, time effect: p < 0.01; condition 757 
effect: p < 0.01; time x condition 758 
interaction effect: p < 0.01), desire for 759 
sweet food (D, time effect: p < 0.01; 760 
condition effect: p < 0.01; time x 761 
condition interaction effect: p < 0.01), 762 
physical tiredness (E, condition effect 763 
p < 0.01; time x condition interaction 764 
effect: p = 0.39), sleepiness (F, time 765 
effect: p = 0.02; condition effect: p < 766 
0.01; time x condition interaction 767 
effect: p = 0.07), energy (G, time effect: 768 
p < 0.01; condition effect: p < 0.01; time 769 
x condition interaction effect: p < 0.01), 770 
and lethargy (H, time effect: p < 0.01; 771 
trial effect: p < 0.01; time x trial 772 
interaction effect: p < 0.01) using 773 
visual analogue scales during an ad 774 
libitum and maximal eating occasion. 775 
*p < 0.05.  776 
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Figure 5. Mean and individual change (%) between a maximal and an ad libitum eating 783 
occasion. iAUC = incremental area under the curve, AUC = area under the curve, GLP-1 = 784 
glucagon-like peptide-1, NEFA = non-esterified fatty acids, PYY = peptide tyrosine-tyrosine, 785 
TAG = triacylglycerol, GIP = glucose-dependent insulinotropic peptide, HR = heart rate, PP = 786 
postprandial, VAS = visual analogue scale.  787 
 788 
